Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	331-344
Journal	New England Journal Of Medicine
Volume	378
DOIs	https://doi.org/10.1056/NEJMoa1708984
Publication status	Published - 25 Jan 2017

Research Beacons, Institutes and Platforms

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{e65b291e70694e319315371b5814497d,

title = "Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin's lymphoma",

author = "John Radford",

year = "2017",

month = jan,

day = "25",

doi = "10.1056/NEJMoa1708984",

language = "English",

volume = "378",

pages = "331--344",

journal = "New England Journal Of Medicine",

issn = "1533-4406",

publisher = "Massachussetts Medical Society",

}